Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines
Abstract
:1. Introduction
2. Conference Section
3. Concluding Remarks
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Edwards, I.R.; Aronson, J.K. Adverse Drug Reactions: Definitions, Diagnosis, and Management. Lancet 2000, 356, 1255–1259. [Google Scholar] [CrossRef] [PubMed]
- Coleman, J.J.; Pontefract, S.K. Adverse Drug Reactions. Clin. Med. 2016, 16, 481–485. [Google Scholar] [CrossRef] [PubMed]
- Sahu, R.K.; Yadav, R.; Prasad, P.; Roy, A.; Chandrakar, S. Adverse Drug Reactions Monitoring: Prospects and Impending Challenges for Pharmacovigilance. Springerplus 2014, 3, 695. [Google Scholar] [CrossRef]
- Harpaz, R.; Odgers, D.; Gaskin, G.; DuMouchel, W.; Winnenburg, R.; Bodenreider, O.; Ripple, A.; Szarfman, A.; Sorbello, A.; Horvitz, E.; et al. A Time-Indexed Reference Standard of Adverse Drug Reactions. Sci. Data 2014, 1, 140043. [Google Scholar] [CrossRef] [PubMed]
- Shchory, M.P.; Goldstein, L.H.; Arcavi, L.; Shihmanter, R.; Berkovitch, M.; Levy, A. Increasing Adverse Drug Reaction Reporting—How Can We Do Better? PLoS ONE 2020, 15, e0235591. [Google Scholar] [CrossRef]
- Güner, M.D.; Ekmekci, P.E. Healthcare Professionals’ Pharmacovigilance Knowledge and Adverse Drug Reaction Reporting Behavior and Factors Determining the Reporting Rates. J. Drug Assess. 2019, 8, 13–20. [Google Scholar] [CrossRef]
- Ouanounou, A.; Ng, K.; Chaban, P. Adverse Drug Reactions in Dentistry. Int. Dent. J. 2020, 70, 79–84. [Google Scholar] [CrossRef]
- Bharti, V.; Bansal, C. Drug-Induced Gingival Overgrowth: The Nemesis of Gingiva Unravelled. J. Indian Soc. Periodontol. 2013, 17, 182. [Google Scholar] [CrossRef]
- Bakhtiari, S.; Sehatpour, M.; Mortazavi, H.; Bakhshi, M. Orofacial Manifestations of Adverse Drug Reactions: A Review Study. Clujul Med. 2018, 91, 27. [Google Scholar] [CrossRef]
- Lu, S.Y. Oral Candidosis: Pathophysiology and Best Practice for Diagnosis, Classification, and Successful Management. J. Fungi 2021, 7, 555. [Google Scholar] [CrossRef]
- Lugović-Mihić, L.; Pilipović, K.; Crnarić, I.; Šitum, M.; Duvančić, T. Differential diagnosis of cheilitis—How to classify cheilitis? Acta Clin. Croat. 2018, 57, 342–351. [Google Scholar] [CrossRef]
- Aswath, N.; Rakshana, R. Drug Induced Erythema Multiforme of the Oral Cavity. Arch. Clin. Cases 2022, 9, 157–160. [Google Scholar] [CrossRef]
- Gupta, R. Drugs Causing Fixed Drug Eruptions: Confirmed by Provocation Tests. Indian J. Dermatol. Venereol. Leprol. 2003, 69, 120. [Google Scholar]
- Jinbu, Y.; Demitsu, T. Oral Ulcerations Due to Drug Medications. Jpn. Dent. Sci. Rev. 2014, 50, 40–46. [Google Scholar] [CrossRef]
- Suryana, K. Lichenoid Reaction Caused by Antihistamines and Corticosteroids. J. Asthma Allergy 2020, 13, 205–211. [Google Scholar] [CrossRef] [PubMed]
- Binmadi, N.O.; Bawazir, M.; Alhindi, N.; Mawardi, H.; Mansour, G.; Alhamed, S.; Alfarabi, S.; Akeel, S.; Almazrooa, S. Medication-Induced Oral Hyperpigmentation: A Systematic Review. Patient Prefer. Adherence 2020, 14, 1961–1968. [Google Scholar] [CrossRef] [PubMed]
- Warner, B.M.; Baer, A.N.; Lipson, E.J.; Allen, C.; Hinrichs, C.; Rajan, A.; Pelayo, E.; Beach, M.; Gulley, J.L.; Madan, R.A.; et al. Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy. Oncologist 2019, 24, 1259–1269. [Google Scholar] [CrossRef]
- Teoh, L.; Moses, G.; McCullough, M.J. A Review and Guide to Drug-Associated Oral Adverse Effects—Dental, Salivary and Neurosensory Reactions. Part 1. J. Oral Pathol. Med. 2019, 48, 626–636. [Google Scholar] [CrossRef] [PubMed]
- Campisi, G.; Mauceri, R.; Bertoldo, F.; Bettini, G.; Biasotto, M.; Colella, G.; Consolo, U.; Di Fede, O.; Favia, G.; Fusco, V.; et al. Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int. J. Environ. Res. Public Health 2020, 17, 5998. [Google Scholar] [CrossRef] [PubMed]
- Srisuriyachanchai, W.; Cox, A.R.; Jarernsiripornkul, N. Exploring Healthcare Professionals’ Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions. Healthcare 2022, 10, 1077. [Google Scholar] [CrossRef]
- Yadav, S. Status of Adverse Drug Reaction Monitoring and Pharmacovigilance in Selected Countries. Indian J. Pharmacol. 2008, 40, S4. [Google Scholar]
- Beninger, P.; Ibara, M.A. Pharmacovigilance and Biomedical Informatics: A Model for Future Development. Clin. Ther. 2016, 38, 2514–2525. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez-Gonzalez, C.; Lopez-Gonzalez, E.; Herdeiro, M.T.; Figueiras, A. Strategies to Improve Adverse Drug Reaction Reporting: A Critical and Systematic Review. Drug Saf. 2013, 36, 317–328. [Google Scholar] [CrossRef] [PubMed]
- Januskiene, J.; Segec, A.; Slattery, J.; Genov, G.; Plueschke, K.; Kurz, X.; Arlett, P. What Are the Patients’ and Health Care Professionals’ Understanding and Behaviors towards Adverse Drug Reaction Reporting and Additional Monitoring? Pharmacoepidemiol. Drug Saf. 2021, 30, 334–341. [Google Scholar] [CrossRef]
- Peters, T.; Soanes, N.; Abbas, M.; Ahmad, J.; Delumeau, J.C.; Herrero-Martinez, E.; Paramananda, M.; Piper, J.; Smail-Aoudia, F.; van der Spuij, W.; et al. Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations. Drug Saf. 2021, 44, 17–28. [Google Scholar] [CrossRef] [PubMed]
- Li, R.; Curtis, K.; Van, C.; Tabish Razi Zaidi, S.; Yeo, C.Y.; Arun Kali, C.; Zaheen, M.; Therese Moujalli, G.; Castelino, R. Why Hospital-Based Healthcare Professionals Do Not Report Adverse Drug Reactions: A Mixed Methods Study Using the Theoretical Domains Framework. Eur. J. Clin. Pharmacol. 2022, 78, 1165–1175. [Google Scholar] [CrossRef] [PubMed]
- Seselja Perisin, A.; Bukic, J.; Rusic, D.; Leskur, D.; Bozic, J.; Mihanovic, A.; Vilovic, M.; Cohadzic, T.; Modun, D. Teaching Pharmacovigilance to Healthcare Students: Identifying Gaps and Opportunities for Improvement. Pharmacy 2021, 9, 147. [Google Scholar] [CrossRef]
- Bepari, A.; Niazi, S.K.; Rahman, I.; Dervesh, A.M. The Comparative Evaluation of Knowledge, Attitude, and Practice of Different Health-Care Professionals about the Pharmacovigilance System of India. J. Adv. Pharm. Technol. Res. 2019, 10, 68–74. [Google Scholar] [CrossRef]
- Chhabra, K.G.; Sharma, A.; Chhabra, C.; Reddy, J.J.; Deolia, S.G.; Mittal, Y. Knowledge, Attitude, and Practices Regarding Pharmacovigilance and Adverse Drug Reaction Reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-Sectional Study. J. Contemp. Dent. Pract. 2017, 18, 964–969. [Google Scholar] [CrossRef]
- Shrestha, S.; Sharma, S.; Bhasima, R.; Kunwor, P.; Adhikari, B.; Sapkota, B. Impact of an Educational Intervention on Pharmacovigilance Knowledge and Attitudes among Health Professionals in a Nepal Cancer Hospital. BMC Med. Educ. 2020, 20, 179. [Google Scholar] [CrossRef]
- Osegueda-Espinosa, A.A.; Sánchez-Pérez, L.; Perea-Pérez, B.; Labajo-González, E.; Acosta-Gio, A.E. Dentists Survey on Adverse Events During Their Clinical Training. J. Patient Saf. 2020, 16, E240–E244. [Google Scholar] [CrossRef]
- Khalaid, M.; Khatoon, M. Pharmacovigilance Education for Dental Students. J. Drug Vigil. Altern. Ther. 2021, 1, 89–91. [Google Scholar] [CrossRef]
- Paudyal, V.; Al-Hamid, A.; Bowen, M.; Hadi, M.A.; Hasan, S.S.; Jalal, Z.; Stewart, D. Interventions to Improve Spontaneous Adverse Drug Reaction Reporting by Healthcare Professionals and Patients: Systematic Review and Meta-Analysis. Expert Opin. Drug Saf. 2020, 19, 1173–1191. [Google Scholar] [CrossRef]
- Leskur, D.; Bozic, J.; Rusic, D.; Seselja Perisin, A.; Cohadzic, T.; Pranic, S.; Modun, D.; Bukic, J. Adverse Drug Reaction Reporting via Mobile Applications: A Narrative Review. Int. J. Med. Inform. 2022, 168, 104895. [Google Scholar] [CrossRef]
- Ganesan, S.; Sandhiya, S.; Reddy, K.C.; Subrahmanyam, D.K.; Adithan, C. The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-Care Professionals in a Tertiary Care Hospital in South India. J. Nat. Sci. Biol. Med. 2017, 8, 203–209. [Google Scholar] [CrossRef]
- Sachdev, R.; Grag, K.; Singh, G.; Mehrotra, V. Pharmacovigilance: An Emerging Trend in Dental Practice of India. RGUHS J. Dent. Sci. 2020, 12, 57–64. [Google Scholar] [CrossRef] [PubMed]
- Ellefsen, B.S.; Larsen, K.R.; Reibel, J.; Kragelund, C. Danish Post-marketing Pharmacosurveillance of Spontaneous Oral Adverse Drug Reactions 2009–2019. Oral Dis. 2023, 1–10. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
La Mantia, G.; Buttacavoli, F.; Panzarella, V.; Colella, G.; Capuano, A.; Sportiello, L.; Parrinello, G.; Morreale, I.; Oteri, G.; Bellavia, G.; et al. Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines. Oral 2023, 3, 411-419. https://doi.org/10.3390/oral3030033
La Mantia G, Buttacavoli F, Panzarella V, Colella G, Capuano A, Sportiello L, Parrinello G, Morreale I, Oteri G, Bellavia G, et al. Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines. Oral. 2023; 3(3):411-419. https://doi.org/10.3390/oral3030033
Chicago/Turabian StyleLa Mantia, Gaetano, Fortunato Buttacavoli, Vera Panzarella, Giuseppe Colella, Annalisa Capuano, Liberata Sportiello, Gaspare Parrinello, Ilaria Morreale, Giacomo Oteri, Giuseppe Bellavia, and et al. 2023. "Oro-Dental Pharmacovigilance in the Digital Age: Promoting Knowledge, Awareness, and Practice in Italy through a Smart Combined System—A Conference at the 30th National Congress of the Italian College of University Professors of Dental Disciplines" Oral 3, no. 3: 411-419. https://doi.org/10.3390/oral3030033